THIAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Thiamine Hydrochloride, and when can generic versions of Thiamine Hydrochloride launch?
Thiamine Hydrochloride is a drug marketed by Abraxis Pharm, Bel Mar, Caplin, Dell Labs, Dr Reddys, Epic Pharma Llc, Eugia Pharma, Fresenius Kabi Usa, Hospira, Luitpold, Mylan Institutional, Parke Davis, Sagent Pharms Inc, Watson Labs, West-ward Pharms Int, and Wyeth Ayerst. and is included in seventeen NDAs.
The generic ingredient in THIAMINE HYDROCHLORIDE is thiamine hydrochloride. There are seven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the thiamine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Thiamine Hydrochloride
A generic version of THIAMINE HYDROCHLORIDE was approved as thiamine hydrochloride by WEST-WARD PHARMS INT on December 31st, 1969.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for THIAMINE HYDROCHLORIDE?
- What are the global sales for THIAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for THIAMINE HYDROCHLORIDE?
Summary for THIAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 16 |
| NDAs: | 17 |
| Finished Product Suppliers / Packagers: | 13 |
| Raw Ingredient (Bulk) Api Vendors: | 140 |
| Clinical Trials: | 83 |
| Patent Applications: | 3,597 |
| DailyMed Link: | THIAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for THIAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Canadian Institutes of Health Research (CIHR) | Phase 3 |
| Hamilton Health Sciences Corporation | Phase 3 |
| Population Health Research Institute | Phase 3 |
Medical Subject Heading (MeSH) Categories for THIAMINE HYDROCHLORIDE
US Patents and Regulatory Information for THIAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080509-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| West-ward Pharms Int | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080575-001 | Approved Prior to Jan 1, 1982 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Dr Reddys | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 080571-002 | Approved Prior to Jan 1, 1982 | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Caplin | THIAMINE HYDROCHLORIDE | thiamine hydrochloride | INJECTABLE;INJECTION | 215692-001 | Mar 6, 2023 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
